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Objective: To retrospectively evaluate the feasibility and effectiveness of three-tube insertion for the treatment of 
postoperative gastroesophageal anastomotic leakage (GEAL). 
Materials and Methods: From January 2007 to January 2011, 28 cases of postoperative GEAL after an esophagectomy with 
intrathoracic esophagogastric anastomotic procedures for esophageal and cardiac carcinoma were treated by the insertion 
of three tubes under fluoroscopic guidance. The three tubes consisted of a drainage tube through the leak, a nasogastric 
decompression tube, and a nasojejunum feeding tube. The study population consisted of 28 patients (18 males, 10 females) 
ranging in their ages from 36 to 72 years (mean: 59 years). We evaluated the feasibility of three-tube insertion to facilitate 
leakage site closure, and the patients’ nutritional benefit by checking their serum albumin levels between pre- and post-
enteral feeding via the feeding tube.
Results: The three tubes were successfully placed under fluoroscopic guidance in all twenty-eight patients (100%). The 
procedure times for the three tube insertion ranged from 30 to 70 minutes (mean time: 45 minutes). In 27 of 28 patients 
(96%), leakage site closure after three-tube insertion was achieved, while it was not attained in one patient who received 
stent implantation as a substitute. All patients showed good tolerance of the three-tube insertion in the nasal cavity. The 
mean time needed for leakage treatment was 21 ± 3.5 days. The serum albumin level change was significant, increasing 
from pre-enteral feeding (2.5 ± 0.40 g/dL) to post-enteral feeding (3.7 ± 0.51 g/dL) via the feeding tube (p < 0.001). The 
duration of follow-up ranged from 7 to 60 months (mean: 28 months).
Conclusion: Based on the results of this study, the insertion of three tubes under fluoroscopic guidance is safe, and also 
provides effective relief from postesophagectomy GEAL. Moreover, our findings suggest that three-tube insertion may be 
used as the primary procedure to treat postoperative GEAL.
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INTRODUCTION
Although the amounts of postoperative anastomotic 
leakage can be rather slight, it is a major source of mortality 
and morbidity (1). In patients with GEAL, quality of life as 
well as the prognosis is very poor. The leading causes of 
death in patients with GEAL are infection and nutritional 
deficiency (2, 3). GEAL is still a therapeutic problem (4, 5) 
and the most effective treatment option for intra thoracic 
GEAL is still controversial. Hence, there is no standardized 
treatment algorithm. Some surgeons recommend aggressive Korean J Radiol 13(2), Mar/Apr 2012 kjronline.org 183
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surgery, while others prefer conservative approaches, such 
as perianastomotic drainage, total parenteralnutrition, 
nasogastric decompression, and the use of broad-spectrum 
antibiotics (6). In this study, we determined the feasibility 
and effectiveness of using a three-tube insertion for the 
treatment of postoperative GEAL. The effect on GEAL 
treatment was evaluated by the time interval of the 
leakages’ closure, and the effect on nutritional status was 
evaluated by measuring serum albumin levels. 
MATERIALS AND METHODS
  
The study population included 28 patients suffering from 
postoperative GEAL and underwent three-tube insertion 
under fluoroscopic guidance from January 2007 to January 
2011. The 28 patients underwent an esophagectomy with 
intrathoracic esophagogastric anastomotic procedures 
for esophageal and cardiac carcinoma. The 28 patients 
consisted of 18 males and 10 females ranging in age 
from 36 to 72 years (mean age: 59 years). Three of the 
patients were TNM stage I esophageal carcinoma patients, 
nine were TNM stage II a, eleven were TNM stage II b, 
and five were TNM stage III. A frozen-section analysis 
of resected margins by a competent pathologist was 
available, and resection margins were found to be cancer-
free in all cases. The retrospective study was approved 
by the Institutional Review Board of our hospital and the 
Ethics Committee of the Institute for Medical Science. The 
procedure was explained to all of the patients in detail, and 
a written consent was obtained from all patients prior to 
the procedure. The patients were divided into two groups: 
one group contained the patients with leakage within 14 
postoperative days, and the other group patients with 
leakage at more than 14 postoperative days (22). Twenty of 
the 28 patients experienced acute leakages, and 8 patients 
had chronic leakages. Signs and symptoms were present in 
all patients (100%) and included high fever in 26 patients, 
shortness of breath in 18 patients, chest pain in eight 
patients, and arrhythmia in six patients. The leakages in the 
24 patients (85.7%) were confirmed by first radiographic 
contrast examination. Four (14.2%) patients initially had 
negative contrast examination results, but they were all 
eventually proven to have anastomotic leakage by repeated 
radiographic contrast examinations 3 to 7 d later. The 
leakage in all patients was first confirmed by a computed 
tomography (CT) examination (Fig. 1A). The three tubes 
were removed after the leak’s closure was testified by CT 
findings.
Interventional Procedure (Fig. 2)
Nasogastric Placement of the Drainage Tube through the 
Leak
All the procedures were performed by two interventional 
radiologists. The patients were in the supine position which 
allowed an easy performance of interventional maneuvers, 
and optimal fluoroscopic visualization of the leak. A 0.035-
inch guidewire (Terumo, Tokyo, Japan) and a 4F H1 catheter 
A B
Fig. 1. Intrathoracic anastomotic leak testified by CT at 1 week postoperation. 
Fistula was located in pleural cavity (A, black arrow). Fistula closed at 25 days (B). Korean J Radiol 13(2), Mar/Apr 2012 kjronline.org 184
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(Terumo, Japan) were advanced into the esophageal 
passage through one nasal cavity under fluoroscopic 
guidance (DSA, Angiostar; Siemens, Germany). The fluid 
collections aspirated through the catheter were sent for 
bacterial culture testing. The prosthesis delivery system 
was then advanced over the guidewire until a 10F Flocare 
polyurethane un-weighted feeding tube (Nutricia, Export 
BV, Amsterdam, the Netherlands) was sent into the vomica. 
We suggested that the backward distance of the tube 
should be less than 5 cm. The Flocare tube was connected 
to a low-pressure continuous vacuum pump whose negative 
pressure was about 8-10 mm Hg. The fluid collection was 
examined every day for color and total quantity. 
Nasogastric Placement of the Feeding Tube into the Jejunum     
A 4F H1 catheter (Terumo, Japan) was advanced into the 
esophageal passage through the ipsilateral nasal cavity. 
When gthe H1 catheter entered the stomach, an Amplatz 
superstiff exchange guidewire (Medi-Tech/Boston Scientific, 
MA, USA) was then inserted via the catheter into the distal 
portion of the jejunum. And 10F Flocare polyurethane un-
weighted feeding tube (Nutricia, Switzerland) was then 
inserted into the jejunum using the guidewire. Contrast 
medium was injected through the Flocare feeding tube to 
verify the success of the manipulation. Essential nutrients 
were poured into the jejunum through the Flocare feeding 
tube. 
A nasogastric decompression tube was placed under 
fluoroscopic guidance when we applied this treatment to 
keep the digestive slice from affluxing into the leakage.
When daily volume of the fluid drainage was reduced to 
5-10 mL, the drainage tube could be gradually pulled back 
(Fig. 3) because the adhesion between the lung and the 
chest wall had already formed at the end of the tube. Under 
the fluoroscopic guidance, the drainage tube was pulled 
back from the distal end to the proximal end of the vomica.
Immediate technical success was defined as the successful 
insertion of the three-tube without any problems. Clinical 
success was defined as closure of the leakage site (Fig. 4), 
as confirmed by a follow-up CT examination (Fig. 1B). A 
Fig. 2. Drain tube (arrow 1) inserted through fistula 
with fluoroscopic guidance and distal tip of drain tube 
was positioned at bottom of abscess cavity (arrow 4). 
Feeding nasojejunum tube (arrow 2) and cases of nasogastric 
decompression tube (arrow 3) were placed during interventional 
operation for postoperative enteral nutrition supply and digestive 
slice drainage.
Fig. 3. Eleven days later, fistula (arrow 1) got smaller, after 
changing position of drainage tube (arrow 2) to keep optimum 
drainage.Korean J Radiol 13(2), Mar/Apr 2012 kjronline.org 185
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patients’ nutritional benefit was evaluated by the serum 
albumin level change between the pre- and post-enteral 
feeding via the feeding tube. The differences in the means 
were evaluated by t tests.
RESULTS
Immediate technical success was achieved in all patients 
(28/28 patients). The chronic group (> 14 postoperative 
day) showed a high incidence of leakage site in the 
thoracic cavity (8/8 = 100%), but the acute group (< 14 
postoperative day) showed a low incidence of leakage site 
in the thoracic cavity (13/20 = 65%) (Table 1). All patients 
had a good tolerance of the three-tube in the nasal cavity. 
Side effects such as shortness of breath were not seen in 
any patient. Only slight nasal mucosa diabrosis was seen in 
two patients.
The procedure times for three-tube insertion ranged from 
30 to 70 min. (mean time: 45 min) and was dependent on 
the detection of the leakage site. Twenty-seven patients 
(27/28 = 96.4%) experienced symptomatic relief, while in 
one patient, though a successful three-tube insertion was 
achieved, the leakage did not close and the patient suffered 
from serious sepsis. A covered nitinol stent (Micro-Tech 
Co, Nanjing, China) was successfully placed to cover the 
leakage site 31 d after receiving the three-tube treatment. 
Sepsis was then under control in 3 weeks. However, the 
patient died 10 months after placement due to sudden 
uncontrollable hematemesis. The mean time interval of the 
leakage treatment was 21 ± 3.5 d. The median follow-up 
time was 28.2 months (range 7-60 months). No patient was 
diagnosed with leak recurrences.
The patient’s nutritional benefit was shown by the 
increasing serum albumin level after enteral feeding via the 
nasojejunum feeding tube. The mean serum albumin level 
was 2.5 ± 0.40 g/dL (1.87-3.68 g/dL) in a 14 day of a pre-
enteral feeding tube period and 3.7 ± 0.51 g/dL (2.52-4.86 
g/dL) in 14 days post-enteral feeding via the feeding tube. 
The differences in the mean significantly increased between 
pre- and post-enteral feeding via the feeding tube (p < 
0.001).
DISCUSSION
Although GEAL occurs in less than 10% of patients, it 
still remains the most feared complication of esophageal 
resection because of its associated high morbidity and 
mortality (7, 8). Although several methods such as surgical 
re-exploration and repair and/or more conservative 
approaches like perianastomotic drainage or broad-spectrum 
antibiotics have been used, no consensus has been reached 
on the best methods of treatment, and the rate of treatment 
failure remains high. It may correlate with general nutritive 
status, anastomotic technique, anastomotic stoma tension, 
anastomotic manner, blood circulation lesion of the 
esophageal or gastric wall, digestive tract obstruction, 
intrathoracic infection, and so on (9-11). HU et al. (12) 
divides the pathophysiological process of GEAL into 3 
stages: diffusion, contained, the elimination of multi-cavity 
vomicas. The anastomotic leakage closed within durations 
of drainage tube insertion with hyperalimentation. In 
our opinion GEAL is a special kind of pyothorax. The key 
in leak management is adequate and effective drainage. 
Fig. 4. Fistula closed on 25 days. Nasojejunum enteral 
supports tube (arrow 1) was retained for enteral nutrition.Korean J Radiol 13(2), Mar/Apr 2012 kjronline.org 186
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When the leakage was limited in the pleural cavity, routine 
chest tube could achieve adequate drainage. But previous 
studies had revealed that most of the contained leaks were 
limited to the mediastinum (7, 8, 13). It is difficult to deal 
with this type of leakage because abscess cavities close to 
the mediastinum are difficult to reach by a conventional 
chest tube. Nasogastric placement of the drainage tube 
through the leak in our study may be a helpful treatment 
for this type of leak. We successfully applied the drainage 
tube through the leak for the treatment of intrathoracic 
anastomotic leaks in 28 patients. Twenty-seven patients 
(27/28 = 96.4%) experienced symptomatic relief. The mean 
time interval of the leakage treatment was 21 ± 3.5 d which 
is much shorter than 32-99 d in the previous study (14, 
15).
In our study one patient received placement of self-
expanding metallic coated stents after failure of the three-
tube treatment. The GEAL was located in the mediastinum 
and thoracic cavity. The vomicas were huge, coated, and 
interlinked. Effective drainage could not be achieved. The 
Table 1. Data in Fluoroscopically Guided by Three-Tube Insertion for Relief of Postoperative Gastroesophageal 
Anastomotic Leakage 
No Age/
Sex Stage Operation 
Procedures
Leak on 
POD
Leakage 
Position
Three-Tube 
Duration (days)
Further 
Treatment
Follow-Up Duration
(months)
1 44/M IIa Left Ivor–Lewis 10 Mediastinum 7 No 24
2 56/M IIb Left Ivor–Lewis 7 Thoracic cavity 12 No 22 (dead due to recurrence)
3 61/M IIa Left Ivor–Lewis 3 Mediastinum 8 No 21
4 63/F IIb Left Ivor–Lewis 15 Thoracic cavity 17 No 31 (dead due to recurrence)
5 70/F IIb Left Ivor–Lewis 9 Thoracic cavity 21 No 39
6 48/F IIa Left Ivor–Lewis 6 Mediastinum 10 No 10
7 55/M IIb Left Ivor–Lewis 7 Thoracic cavity 20 No 29 (dead due to recurrence)
8 54/M I Left Ivor–Lewis 6 Thoracic cavity 21 No 60
9 60/F IIa Left Ivor–Lewis 10 Thoracic cavity 18 No 18 (dead due to recurrence)
10 61/M IIa Left Ivor–Lewis 8 Thoracic cavity 22 No 8
11 64/M IIb Left Ivor–Lewis 18 Thoracic cavity 24 No 34 (dead due to recurrence)
12 69/M IIa Left Ivor–Lewis 21
Mediastinum-thoracic 
cavity
31 No 32 (dead due to recurrence)
13 49/F III Left Ivor–Lewis 5 Mediastinum 8 No 33 (dead due to recurrence)
14 36/M IIb Left Ivor–Lewis 12 Thoracic cavity 15 No 27
15 71/M I Left Ivor–Lewis 19 Thoracic cavity 22 No 49 (dead due to recurrence)
16 67/F IIb Left Ivor–Lewis 20 Thoracic cavity 13 No 34 (dead due to recurrence)
17 51/F IIa Left Ivor–Lewis 11 Mediastinum 12 No 48
18 63/M III Left Ivor–Lewis 5 Thoracic cavity 14 No 9 (dead due to recurrence)
19 66/M IIa Left Ivor–Lewis 4 Thoracic cavity 19 No 21
20 72/F I Left Ivor–Lewis 18 Mediastinum 13 No 60
21 60/F III Left Ivor–Lewis 7 Thoracic cavity 24 No 17 (dead due to recurrence)
22 57/M IIa Left Ivor–Lewis 9 Mediastinum 15 No 22
23 59/M IIb Left Ivor–Lewis 6 Thoracic cavity 21 No 29 (dead due to recurrence)
24 62/F III Left Ivor–Lewis 5 Thoracic cavity 25 No 27 (dead due to recurrence)
25 61/M IIb Left Ivor–Lewis 8 Thoracic cavity 17 No 31
26 64/M III Left Ivor–Lewis 22
Mediastinum-thoracic 
cavity Failure Stent 10 (dead due to recurrence)
27 47/M IIb Left Ivor–Lewis 19 Thoracic cavity 23 No 38 (dead due to recurrence)
28 55/M IIb Left Ivor–Lewis 4 Mediastinum 18 No 7
Note.— POD = postoperative daysKorean J Radiol 13(2), Mar/Apr 2012 kjronline.org 187
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stent was placed on the 31 d after receiving three-tube 
treatment. The patient died on 10 months after placement 
due to uncontrollable hematemesis. Previous studies (16, 
17) revealed that certain problems might be associated 
with stent placement and removal: insufficient closure of 
the leaks, stent migration and development of strictures 
after stent removal, severe complications: such as bleeding 
and food blockage, hard removal because of the growth 
of granulation tissue, et al. But other studies (18-21) 
concluded that stent placement has been shown to be an 
excellent treatment in patients without sepsis and large 
mediastinal abscess formation. In our view, the leakage 
in our study can be deemed as optimal and, it is not very 
suitable to insert the stent leader. Once the stent is placed, 
it had to be got out which is afflicting for patient. Some 
patients died of a large amount of haematemesis due to 
the repeated friction between the stent and fistula (13) 
over the course of the stents’ dislodgment. Moreover, we 
know the accurate time of the closure of the leakages 
while the stent treatment can’t support it. We can monitor 
the leakage by contrast-medium injection while the stent 
treatment can’t.
The enteric feeding might contribute to the general 
nutritional correction from the postsurgical status, and this 
might contribute to the closure of anastomotic leakage. A 
routine jejunostomy to nutritional support is a traumatic 
method. But the nasogastric placement of nutritious tube 
of jejunum under the fluoroscopic guidance can avoid the 
injury of the jejunum. Moreover  total parenteral nutrition 
is expensive and it has a high rate of complications. 
The enteral feeding allows for a high serum albumin 
level compared to total parenteral nutrition (22). In our 
study, the patient nutrition benefit showed a significantly 
increased serum albumin level after enteral feeding (p 
< 0.001). Han et al. (22) reported that they reached a 
successfull relief of the postoperative gastrointestinal 
anastomotic obstruction and leakage by fluoroscopically 
guided feeding tube insertion in thirty-four patients. In our 
view food intake can irritate the mucosa at the anastomotic 
site. In addition, the digestive slice can continuously enter 
the chest space from the fistula. As intrathoracic pleural 
adhesion has not formed, it is easy to result in diffusion, 
chemical, and purulent pleuritis; and, eventually, severe 
sepsis, consumption, and death. In our study, no patient 
suffered severe sepsis. Ott et al. (23) had reported a 
success rate for fluoroscopic placement of 90%, with a tube 
placed into the jejunum in 53% of patients and placed into 
the duodenum in 47% of the patients. In the present study, 
the tubes were placed fluoroscopically in the jejunum in 
all patients, and the mean procedure time was 45 minutes. 
Moreover, the endoscopic and fluoroscopic placement of 
postpyloric feeding tubes can be performed safely and 
accurately at the bedside for critically ill patients (24). 
Fluoroscopic placement requires less additional sedation, 
whereas endoscopic placement allows direct visualization 
of the gastric and duodenal anatomy, and it can be 
performed without additional X-ray support (24). In our 
study, fluoroscopic guidance using a catheter and guidewire 
allowed for the anastomotic sites to be found easily and 
there were unhindered passages of the catheter into the 
jejunum because the catheter has a considerably smaller 
diameter than the endoscopy instrument.
The nasogastric decompression tube was routinely placed 
when we applied this kind of conservative treatment. Jiang 
et al. (13) reported that the nasogastric decompression 
tubes were unnecessary in this management of the 
intrathoracic esophagogastric anastomotic leak because the 
drainage volume of the tube was low. However, our clinical 
observation revealed that the drainage volume of the 
nasogastric decompression tube was not low. So we retained 
the tube.
There are some limitations in our study. One of the 
limitations was the retrospective and nonrandomized study 
design. In the coming days, a prospective and randomized 
study will be designed to evaluate clinical efficacy in three-
tube vs stent placement for the treatment of postoperative 
GEAL. The other one was that some patients feel discomfort. 
But in our study all patients had a good tolerance of three-
tube in nasal cavity. Shortness of breath was seen in no 
patient. Only slight nasal mucosa diabrosis was seen in two 
patients. 
In conclusion, three-tube insertion under fluoroscopic 
guidance was found to provide safe and effective relief 
of GEAL. We suggest that three-tube insertion should be 
considered as an alternative therapeutic option for patients 
having GEAL.
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